ZJYL Jin Medical International Ltd.
Fundamentals / CIK 0001837821 / USDJin Medical International Ltd. reported $20.69M in revenue and net income of $1.19M for the fiscal year ended September 30, 2025 (down 12.0% year over year), with a 29.2% gross margin and a 2.9% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ZJYL in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$20.69M -12.0% YoY
-
Operating Income FY 2025$608K 2.9% margin
-
Net Income FY 2025$1.19M 5.8% net margin
-
Diluted EPS FY 2025$0.01 Split-adjusted
-
Free Cash Flow FY 2025-$3.73M -18.0% FCF margin
-
Cash & ST Investments Sep 30, 2025$29.63M Total debt: $18.91M
Annual revenue and net income
5 fiscal years (2021 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|
| Revenue | $20.69M | $23.50M | $19.82M | $19.19M | $20.76M |
| Cost of Revenue | $14.64M | $14.00M | $13.04M | $12.99M | $14.40M |
| Gross Profit | $6.04M | $9.50M | $6.78M | $6.20M | $6.36M |
| Research & Development | $1.56M | $1.50M | $1.54M | $1.89M | $1.57M |
| Selling, General & Admin | $3.88M | $4.37M | $2.37M | $2.18M | $2.16M |
| Total Operating Expenses | $5.44M | $5.86M | $3.92M | $4.07M | $3.73M |
| Operating Income | $608K | $3.64M | $2.87M | $2.13M | $2.63M |
| EBITDA | $852K | $3.88M | $3.09M | $2.49M | $2.98M |
| Interest Income | $789K | $467K | $183K | $182K | $64K |
| Income Before Tax | $1.60M | $4.18M | $3.22M | $2.74M | $2.88M |
| Income Tax Expense | $215K | $764K | $344K | $36K | $249K |
| Net Income | $1.19M | $3.68M | $2.88M | $2.71M | $2.63M |
| Basic EPS | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 |
| Diluted EPS | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 |
| Basic Shares Outstanding | 156.5M | 156.5M | 145.1M | 135.0M | 135.0M |
| Diluted Shares Outstanding | 156.5M | 156.5M | 145.1M | 135.0M | 135.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $7.46M | $8.14M | $6.93M | -- |
| Short-Term Investments | $22.17M | $18.62M | $9.77M | $2.28M |
| Cash & Short-Term Investments | $29.63M | $26.76M | $16.70M | -- |
| Accounts Receivable, Net | $5.81M | $5.91M | $3.28M | $3.83M |
| Inventory | $4.92M | $5.17M | $5.05M | $6.72M |
| Total Current Assets | $44.14M | $42.82M | $31.12M | $18.90M |
| Property, Plant & Equipment, Net | $7.90M | $1.46M | $1.48M | $1.63M |
| Intangible Assets | $1.10M | $1.15M | $154K | -- |
| Total Non-Current Assets | $9.23M | $2.98M | $1.79M | $2.04M |
| Total Assets | $53.37M | $45.80M | $32.90M | $20.94M |
| Accounts Payable | $3.26M | $3.01M | $3.39M | $4.11M |
| Short-Term Debt | $18.84M | $11.32M | $4.11M | -- |
| Deferred Revenue (Current) | $495K | $671K | -- | -- |
| Total Current Liabilities | $23.80M | $17.15M | $8.92M | $5.70M |
| Total Non-Current Liabilities | $0 | $96K | $0 | $0 |
| Total Liabilities | $23.80M | $17.25M | $8.92M | $5.70M |
| Total Debt (incl. Leases) | $18.91M | $11.60M | $4.11M | -- |
| Common Stock | $7.8K | $7.8K | $7.8K | $6.8K |
| Retained Earnings | $20.94M | $20.02M | $16.93M | $14.41M |
| Accumulated Other Comp. Income | -$924K | -$556K | -$1.40M | -$911K |
| Total Stockholders' Equity | $29.64M | $28.82M | $23.98M | $15.24M |
| Total Equity | $29.57M | $28.55M | $23.98M | $15.24M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $7.46M | $8.14M | $6.93M | -- |
| Short-Term Investments | $22.17M | $18.62M | $9.77M | $2.28M |
| Cash & Short-Term Investments | $29.63M | $26.76M | $16.70M | -- |
| Accounts Receivable, Net | $5.81M | $5.91M | $3.28M | $3.83M |
| Inventory | $4.92M | $5.17M | $5.05M | $6.72M |
| Total Current Assets | $44.14M | $42.82M | $31.12M | $18.90M |
| Property, Plant & Equipment, Net | $7.90M | $1.46M | $1.48M | $1.63M |
| Intangible Assets | $1.10M | $1.15M | $154K | -- |
| Total Non-Current Assets | $9.23M | $2.98M | $1.79M | $2.04M |
| Total Assets | $53.37M | $45.80M | $32.90M | $20.94M |
| Accounts Payable | $3.26M | $3.01M | $3.39M | $4.11M |
| Short-Term Debt | $18.84M | $11.32M | $4.11M | -- |
| Deferred Revenue (Current) | $495K | $671K | -- | -- |
| Total Current Liabilities | $23.80M | $17.15M | $8.92M | $5.70M |
| Total Non-Current Liabilities | $0 | $96K | $0 | $0 |
| Total Liabilities | $23.80M | $17.25M | $8.92M | $5.70M |
| Total Debt (incl. Leases) | $18.91M | $11.60M | $4.11M | -- |
| Common Stock | $7.8K | $7.8K | $7.8K | $6.8K |
| Retained Earnings | $20.94M | $20.02M | $16.93M | $14.41M |
| Accumulated Other Comp. Income | -$924K | -$556K | -$1.40M | -$911K |
| Total Stockholders' Equity | $29.64M | $28.82M | $23.98M | $15.24M |
| Total Equity | $29.57M | $28.55M | $23.98M | $15.24M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|
| Net Income | $1.38M | $3.42M | $2.88M | $2.71M | $2.63M |
| Depreciation & Amortization | $243K | $238K | $226K | $363K | $347K |
| Change in Receivables | $1.28M | -$2.39M | $349K | $242K | $159K |
| Change in Inventory | $168K | $80K | $1.56M | -$504K | $459K |
| Change in Payables | $287K | -$500K | -$647K | -$810K | -$369K |
| Operating Cash Flow | $2.90M | -$1.21M | $3.11M | $1.58M | $5.84M |
| Capital Expenditure | -$6.63M | -$145K | -$114K | -$40K | -$43K |
| Free Cash Flow | -$3.73M | -$1.35M | $2.99M | $1.54M | $5.80M |
| Acquisitions, Net | -$500K | -- | -- | -- | -- |
| Investing Cash Flow | -$10.79M | -$9.51M | -$7.73M | -$121K | -$1.07M |
| Common Stock Issued | -- | $312K | -- | -- | -- |
| Financing Cash Flow | $7.35M | $11.65M | $6.91M | $122K | -$2.87M |
| Net Change in Cash | -$675K | $1.21M | $2.14M | $1.12M | $2.01M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|
| Gross Margin | 29.2% | 40.4% | 34.2% | 32.3% | 30.6% |
| Operating Margin | 2.9% | 15.5% | 14.5% | 11.1% | 12.7% |
| Net Profit Margin | 5.8% | 15.6% | 14.5% | 14.1% | 12.7% |
| Return on Equity (ROE) | 4.0% | 12.8% | 12.0% | 17.8% | -- |
| Return on Assets (ROA) | 2.2% | 8.0% | 8.7% | 12.9% | -- |
| Current Ratio | 1.86x | 2.50x | 3.49x | 3.31x | -- |
| Quick Ratio | 1.65x | 2.19x | 2.92x | 2.14x | -- |
| Debt to Equity | 0.64x | 0.40x | 0.17x | -- | -- |
| Revenue Growth (YoY) | -12.0% | +18.6% | +3.3% | -7.6% | -- |
| Gross Profit Growth (YoY) | -36.4% | +40.1% | +9.5% | -2.6% | -- |
| Operating Income Growth (YoY) | -83.3% | +26.9% | +34.6% | -19.0% | -- |
| Net Income Growth (YoY) | -67.6% | +27.7% | +6.3% | +2.8% | -- |
| EPS Growth (YoY) | -50.0% | 0.0% | 0.0% | 0.0% | -- |
| Operating Cash Flow Growth (YoY) | -- | -138.9% | +96.5% | -72.9% | -- |
| Free Cash Flow Growth (YoY) | -- | -145.2% | +94.3% | -73.4% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.